Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 4Fatigue 3Breast Neoplasms 3Neoplasms 2Rectal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Asthenia 1Arthralgia 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × methyl hydroxyethyl cellulose × Clear all
NCT02167932 2018-06-06

The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast Cancer

UNC Lineberger Comprehensive Cancer Center

Completed
127 enrolled
Breast

Breast Neoplasms, Motor Activity, Neoplasms

NCT02191982 2017-09-12

S-PACT

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed
44 enrolled

Asthenia, Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡